Obstacle Negotiation in Older People With and Without Vision Impairment
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: Obstacle characteristics.
- Who it may be relevant to
- Registry conditions: Low Vision. Basic parameters: from 18 years · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- United States
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Official title
Impact of Stepping Over Obstacles of Different Contrast and Height on Gait and Eye Movements in Older Adults With and Without Vision Impairment
Overview
Falls are common among people with vision impairment and can lead to devastating health consequences. Understanding the functions of vision and how the visual characteristics of obstacles in the walking path impact the gait of people with vision impairment is necessary to create strategies to prevent falls in this population. The purpose of this study is to determine how adults with vision impairment change their gait behavior when stepping over obstacles that vary in height and contrast to the ground. We will then determine the mechanisms of gaze behavior that correlate to the gait behavior.
Interventions
- Other Obstacle characteristics
In the walking trials, when an obstacle is present, the obstacle height and obstacle contrast level will be varied across the trial repetitions. Each participant will be exposed to obstacles of two heights: the first will be 1 centimeter in height, and the second will be approximately 20% of the subject's leg length (ranging in physical height between 15 - 22 centimeters to cover a range of leg lengths in the population). Obstacles (of both heights) will also be painted such that their measure
Primary outcome measures
- Vertical foot clearance, lead limb [Time frame: During a single intervention visit (Study Visit 2), up to 2-3 hours in duration.]
- Foot placement variability [Time frame: During a single intervention visit (Study Visit 2), up to 2-3 hours in duration.]
- Obstacle crossing speed [Time frame: During a single intervention visit (Study Visit 2), up to 2-3 hours in duration.]
- Gaze sequencing [Time frame: During a single intervention visit (Study Visit 2), up to 2-3 hours in duration.]
Eligibility criteria
Inclusion criteria
- Age 18 or over
- Able to walk independently
- Either have normal vision, or impaired vision.
- Impaired vision is defined as binocular visual acuity of 20/25 or worse with or without a central scotoma; and/or binocular visual field that is restricted to an average of 100 degrees in diameter or less
- Control subjects will have visual acuity of 20/40 or better.
Exclusion criteria
- Not cleared by a medical provider for moderate physical activity
- Self-report or have a history of: vestibular disorder or deafness
- Medical history of any condition that affects the ability to walk for up to 2 hours with breaks, such as feeling dizzy or faint, chest pain, palpitations, pain or numbness in the legs, shortness of breath,
- Cognitive limitations either by self-report or a score on the Mini Mental State Exam below 24 (out of 30)
- Walking or gait abnormalities, such as those caused from an injury, surgery, severe arthritis, or neurological condition such as Parkinson's disease
- Unable to walk without any walking aids such as a walker, cane, guide dog, or oxygen tank.
- Does not speak English
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: Yes
Study design
- Allocation
- Non-randomized
- Model
- Parallel assignment
- Masking
- Open label
- Primary purpose
- Basic science
Study locations
United States · 1 center
- Indiana University — Bloomington
Identifiers
NCT: NCT05888441 · 16447